315 studies found for:    Pinched Nerve
Show Display Options
Rank Status Study
21 Enrolling by invitation A Randomized Trial Measuring the Effect of Decision Aids on Patients' Satisfaction, Conflict of Decision-making and Clinical Outcome
Conditions: Trapeziometacarpal Arthrosis;   Carpal Tunnel Syndrome;   Cubital Tunnel Syndrome;   Distal Radius Fractures;   Trigger Finger
Intervention: Behavioral: Decision Aid
22 Not yet recruiting Immobilization Versus Immediate Motion After Anterior Submuscular Ulnar Nerve Transposition
Condition: Cubital Tunnel Syndrome
Interventions: Procedure: Immobilization followed by protected range of motion;   Procedure: Immediate range of motion
23 Completed Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy
Condition: Diabetic Neuropathy
Intervention: Genetic: hVEGF-A
24 Completed Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.
Condition: Diabetic Neuropathy, Painful
Intervention: Drug: Pregabalin
25 Completed Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy
Condition: Painful Diabetic Neuropathy
Intervention: Drug: Cannabis
26 Recruiting Exercise-facilitated Neurorehabilitation in Diabetic Neuropathy
Condition: Diabetic Neuropathy
Intervention: Behavioral: Exercise
27 Completed A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
Conditions: Postherpetic Neuralgia;   Diabetic Neuropathy;   Complex Regional Pain Syndrome;   Carpal Tunnel Syndrome;   HIV Neuropathy;   Idiopathic Sensory Neuropathy;   Peripheral Neuropathy
Interventions: Drug: Placebo Capsules + Placebo Patch;   Drug: Placebo capsules + Lidoderm®;   Drug: Gabapentin + Placebo;   Drug: Gabapentin + Lidoderm®;   Drug: Gabapentin 300 mg capsules 1800 mg/day + placebo patch;   Drug: Gabapentin 1800 mg/day + Lidoderm patch
28 Completed A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy
Condition: Painful Diabetic Neuropathy
Intervention: Drug: SPM 929
29 Terminated A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy
Condition: Diabetic Peripheral Neuropathy
Interventions: Biological: Tanezumab;   Biological: placebo
30 Recruiting Objective Measures of Nerve Integrity, Posture, Gait and Blood Flow After Nerve Decompression in Diabetic Neuropathy Patients
Condition: Diabetic Peripheral Neuropathy
Intervention: Procedure: Arm A - Non-Diabetic, Gait and Balance
31 Terminated Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes
Condition: Diabetic Neuropathy
Interventions: Procedure: Placebo;   Procedure: Pulsatile IV insulin delivery (humalog, humulin, novolog)
32 Recruiting A Study to Determine if There is a Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) and Phosphodiesterase Type 5 (PDE5) Inhibitors
Condition: Nonarteritic Anterior Ischemic Optic Neuropathy
Intervention: Drug: PDE5 Inhibitors
33 Recruiting Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)
Conditions: Cancer;   Peripheral Neuropathy
Interventions: Drug: Ethosuximide;   Drug: Placebo
34 Unknown  Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A)
Conditions: Charcot-Marie-Tooth Disease;   Charcot-Marie-Tooth Disease Type 1A
Interventions: Other: TreSPE;   Other: SPE
35 Not yet recruiting A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy
Conditions: Diabetic Neuropathy;   Chemotherapy Induced Neuropathy;   HIV Neuropathy;   Trauma Induced Neuropathy
Intervention: Drug: Neuron012703 (Medical Food)
36 Completed Painful HIV Neuropathy and Alpha-Lipoic Acid
Conditions: HIV;   Peripheral Neuropathy
Intervention: Drug: Alpha-Lipoic Acid
37 Terminated
Has Results
A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy
Condition: Peripheral Neuropathy, Chemotherapy-induced
Interventions: Drug: PROCRIT 40,000 IU QW;   Drug: Placebo
38 Not yet recruiting L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1
Condition: Hereditary Sensory and Autonomic Neuropathy Type I
Interventions: Drug: L-serine;   Drug: placebo
39 Completed Exercise Capability and Training Effects in Diabetic Patients With Neuropathy
Conditions: Diabetes Mellitus;   Peripheral Neuropathy
Interventions: Behavioral: exercise training;   Behavioral: usual care
40 Completed Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
Conditions: Diabetic Neuropathies;   Diabetes Mellitus, Insulin-Dependent;   Diabetes Mellitus, Non-Insulin-Dependent
Intervention: Drug: Ruboxistaurin mesylate

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years